Prostate Cancer is a peer-reviewed english-language open-access journal published by Wiley in United Kingdom, operating under an open-access model since 2011. The journal covers Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology and Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Prostate Cancer; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
male urogenital diseases, prostatic neoplasms, prostate cancer
At a glance
- Publisher
- Wiley
- Country
- United Kingdom
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2011
ISSN
- 2090-3111
- electronic
- 2090-312X
Frequently asked questions
Is Prostate Cancer peer-reviewed?
Yes — Prostate Cancer operates a Anonymous peer review review process.
Does Prostate Cancer charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Prostate Cancer publish?
Prostate Cancer publishes research in Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology and Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Prostate Cancer accept?
Prostate Cancer accepts manuscripts in English.
What is the ISSN of Prostate Cancer?
ISSN:
2090-3111 (print) · 2090-312X (electronic).How do I submit a manuscript to Prostate Cancer?
Submit through the journal's official portal: visit submission page →